Skip to main content
Clinical Trials/CTRI/2018/06/014498
CTRI/2018/06/014498
Recruiting
Phase 2

A PROSPECTIVE INTERVENTIONAL STUDY FOR THE ROLE OF ZINC SULPHATE ON PAIN SEVERITY AND DURATION IN PRIMARY DYSMENORRHEA - ZNDY

Dr Ravali Ch0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- primary dysmenorrheaHealth Condition 2: N944- Primary dysmenorrhea
Sponsor
Dr Ravali Ch
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Ravali Ch

Eligibility Criteria

Inclusion Criteria

  • Regular menstrual cycles (every 28 \+/\- 7 days) and with a history of primary dysmenorrhea for at least one day per month

Exclusion Criteria

  • Evidence of gynecological disease (such as endometriosis, adenomyosis), significant
  • medical history, women on antibiotics such as Quinolones, tetracyclineâ??s and on
  • thiazides, Penicillamine are excluded from the study

Outcomes

Primary Outcomes

Not specified

Similar Trials